PS

Praveena Singh

Active Director Director DIN 11532213
DIN 11532213 First appointment Feb 2026 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value •••• Premium profile

About Praveena Singh

Data last updated:

Praveena Singh is a Director at Pumex Pharmaceuticals Private Limited (since 2026). The company operates in Chemicals. Pumex Pharmaceuticals Private Limited reported revenue of ₹26,149 (FY 2022).

DIN 11532213
Primary Designation Director
Industry Chemicals
First Appointment 09 Feb 2026
Largest company Pumex Pharmaceuticals Private Limited · ₹26,149 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Feb 2026₹26,149 (FY 2022)Active

Board colleagues of Praveena Singh

NameDINCompanyDesignation
Rajeev Singh01541094Pumex Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Pumex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Praveena Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Praveena Singh

Praveena Singh currently holds 1 directorship: Pumex Pharmaceuticals Private Limited (Director, since 09 Feb 2026, revenue ₹26,149 (FY 2022)).

Praveena Singh was first appointed on 09 Feb 2026 as Director at Pumex Pharmaceuticals Private Limited.

The current boards of Praveena Singh's companies include Rajeev Singh (Pumex Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available